[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Pharmaceuticals Company Research Reports

Pharmaceuticals companies are involved into development, production as well as marketing of an extensive variety of medicines. The pharmaceuticals industry is represented by innumerable companies. Small biotechnology and biopharmaceutical manufacturers, mid-sized specialty companies, large multi-nationals enterprises are amid the world pharma companies.

Appearance of new products; introduction of new product costs structures and modes of healthcare delivery; modification of product cost, offerings and design; growing public scrutiny; scientific researches in the fields of nanotechnology, bioengineering, etc. are among trends contributing to changes in the pharmaceutical industry.

Johnson & Johnson, Pfizer, Inc., Roche Holding AG, Novartis International AG, Abbott Laboratories, etc. are amid behemoths of the pharmaceutical industry.

Within this MarketPublishers’ catalogue there are innumerable reports featuring pharmaceutical companies’ overviews. The research reports provide a state-of-the-art picture of the pharma market including the analyses of the pharmaceuticals companies. Evaluation of companies’ strategies and data on products offerings are available in the research studies.

Publications found: 3,987
Sort by:

Kimia Farama Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Kimia Farama Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

King Pharmaceuticals Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

King Pharmaceuticals Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Kissei Pharmaceutical Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Kissei Pharmaceutical Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Kiwa Bio-Tech Products Group Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Kiwa Bio-Tech Products Group Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Kolon Life Science Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Kolon Life Science Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Komipharm International Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Komipharm International Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Kopran Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Kopran Limited Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Korea United Pharm Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Korea United Pharm Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Korean Drug Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Korean Drug Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Kotra Industries Bhd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Kotra Industries Bhd Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Kpx Life Science Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Kpx Life Science Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Krebs Biochemicals & Industries Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Krebs Biochemicals & Industries Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Kukje Pharmaceutical Industrial Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Kukje Pharmaceutical Industrial Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Kun Run Biotechnology, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Kun Run Biotechnology, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Kunming Pharmaceutical Corp Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Kunming Pharmaceutical Corp Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Alvogen Korea Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Alvogen Korea Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 99 pages

KV Pharmaceutical Co. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

KV Pharmaceutical Co. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Kwang Dong Pharmaceutical Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Kwang Dong Pharmaceutical Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

KYORIN Holdings, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

KYORIN Holdings, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Kyowa Hakko Kirin Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Kyowa Hakko Kirin Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Kyto BioPharma Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Kyto BioPharma Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Kyung Dong Pharmaceutical Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Kyung Dong Pharmaceutical Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 79 pages

Kyung Nam Pharm Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Kyung Nam Pharm Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

La Jolla Pharmaceutical Co. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

La Jolla Pharmaceutical Co. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

LAB Research, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

LAB Research, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Labopharm Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Labopharm Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Laboratorios Almirall SA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Laboratorios Almirall SA Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Laboratorios Andromaco S.A. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Laboratorios Andromaco S.A. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Laboratorios Farmaceuticos ROVI, S.A. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Laboratorios Farmaceuticos ROVI, S.A. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Laboratorios Farmindustria S.A. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Laboratorios Farmindustria S.A. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Lactose (India) Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Lactose (India) Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Lannett Company, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Lannett Company, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Lansen Pharmaceutical Holdings Co., Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Lansen Pharmaceutical Holdings Co., Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Lavipharm SA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Lavipharm SA Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Layerlab AB Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Layerlab AB Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Lee's Pharmaceutical Holdings Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Lee's Pharmaceutical Holdings Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Lescarden Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Lescarden Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Lexicon Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Lexicon Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

LG Life Sciences Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

LG Life Sciences Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Life Nutrition Products, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Life Nutrition Products, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Life Technologies Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Life Technologies Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Veloxis Pharmaceuticals A/S Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Veloxis Pharmaceuticals A/S Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

LifeHealthCare Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

LifeHealthCare Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Lifevantage Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Lifevantage Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Ligand Pharmaceuticals Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ligand Pharmaceuticals Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Lightlake Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Lightlake Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Lijun International Pharmaceutical (Holding) Co Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Lijun International Pharmaceutical (Holding) Co Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Lincoln Pharmaceuticals Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Lincoln Pharmaceuticals Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Linical Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Linical Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

LipidViro Tech Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

LipidViro Tech Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Filters

Search

Publishers

2,237
1,678
37
6
2
1
1
21
2
1
1

Regions

1,352
441
361
240
234
179
155
127
100
90
84
73
65
62
44
27
27
24
20
19
19
19
19
18
17
15
14
13
12
11
11
8
7
7
6
5
5
5
5
4
3
2
2
2
2
2
2
2
2
2
2
2
2
1
1
13

Price

Date

Pages

Offers